Sigachi Laboratories Limited Unlisted Share Price
As of , the indicative unlisted share price of Sigachi Laboratories Limited is ₹52 per share. This is an over-the-counter reference price, not a stock-exchange quote.
As of , Sigachi Laboratories Limited is not listed on any Indian stock exchange (NSE or BSE) — its shares trade in the unlisted, over-the-counter (pre-IPO) market.
| Price / unit | ₹52 |
|---|---|
| Market cap | ₹35 Cr |
| Min. investment | ₹10,140 |
| Lot size | 195 |
| P/E ratio | 29.55 |
| P/B ratio | 0.89 |
What is Sigachi Laboratories Limited?
Sigachi Laboratories Limited is an unlisted Healthcare company whose shares trade in India's over-the-counter (pre-IPO) market and settle in demat form (NSDL/CDSL).
Sigachi Laboratories Limited is a Telangana-based pharmaceutical manufacturer incorporated in 1994, operating in the bulk drugs and drug intermediates space. The company produces active pharmaceutical ingredients and intermediate chemical compounds that serve as the building blocks for finished formulations, supplying these inputs to the broader pharmaceutical and chemical manufacturing chain. Its operations are anchored at facilities in the Bonthapally industrial belt of Sangareddy district, a region that has long been a hub for India's bulk-drug and API production. Beyond its core manufacturing income, the company's reported revenue also reflects earnings from interest on loans, inter-corporate deposits, and fixed deposits, indicating a treasury component alongside its industrial activity. With a face value of ₹10 per share and a relatively concentrated equity base of roughly 6.75 million shares, it is a small-capitalisation enterprise by Indian standards. A notable point of distinction is that Sigachi Laboratories Limited is a separate legal entity from the NSE- and BSE-listed Sigachi Industries Limited, despite the shared "Sigachi" name and a common heritage in the pharmaceutical sector. Sigachi Laboratories is admitted on the Metropolitan Stock Exchange of India (MSEI), a regional exchange with limited active trading, and it does not trade on the NSE or BSE main boards. As a result, its shares are commonly transacted in the over-the-counter unlisted market. This combination of attributes is what draws attention to the company in the unlisted segment. Investors and market participants tracking pharmaceutical and API names often monitor such MSEI-admitted, thinly traded companies because they sit outside mainstream exchange coverage. The shares are dematerialised through NSDL and CDSL, which supports off-market transfers. Reported book value per share has historically run above the face value, reflecting accumulated reserves. As with all unlisted securities, available information is less standardised than for actively listed peers, and the indicative price reflects negotiated private-market dealing rather than continuous exchange-driven price discovery.
Explore more unlisted shares
Other companies in our curated selection.
Frequently asked questions
No. As of 16 July 2026, Sigachi Laboratories Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
The minimum lot is 195 share(s); at the indicative price of about ₹52, that is approximately ₹10,140. Indicative reference, not a quote.
As of 16 July 2026, the indicative unlisted share price of Sigachi Laboratories Limited is ₹52 per share. This is an over-the-counter reference price, not a stock-exchange quote.
The ISIN of Sigachi Laboratories Limited is INE368H01018. An ISIN is the unique 12-character code that identifies a company's shares in the depository system; this one is verified against NSDL (the National Numbering Agency). You need it to hold or transfer these unlisted shares in your NSDL or CDSL demat account.
Sigachi Laboratories Limited is a Telangana-based pharmaceutical company incorporated in 1994. It manufactures bulk drugs and drug intermediates (active pharmaceutical ingredients and related chemical compounds) used as inputs in finished pharmaceutical formulations, with manufacturing facilities in the Bonthapally area of Sangareddy district.
Sigachi Laboratories Limited is not listed or actively traded on the NSE or BSE main board; it is admitted on the Metropolitan Stock Exchange of India (MSEI), a regional exchange with limited trading. It should not be confused with the separately listed Sigachi Industries Limited. Its shares are generally transacted in the over-the-counter unlisted market through off-market transfers between a buyer and seller, settled into a demat account via NSDL or CDSL. This is general information, not investment advice.
Because the shares are not actively traded on a major exchange, the indicative price reflects negotiated dealing in the private unlisted market rather than continuous exchange-based price discovery. Factors that participants typically consider include the company's reported financials such as book value and earnings per share, sector conditions in the bulk-drug space, share availability and demand, and overall sentiment. The indicative figure is market data only and can vary between sources and over time.
Key identifiers include CIN L24230TG1994PLC018786 and ISIN INE368H01018, with a face value of ₹10 per share and incorporation in 1994. The company has a relatively small equity base of roughly 6.75 million shares and is registered in Telangana. Its income is derived mainly from pharmaceutical products (bulk drugs and drug intermediates) along with interest income. These details are factual and provided for information only.
They can. If the company declares a dividend, unlisted shareholders are eligible like any other shareholder. Many unlisted firms reinvest profits, so dividends are not guaranteed.
After listing, unlisted shares convert into regular listed shares in your demat account and can be traded on the exchange, usually once any applicable SEBI lock-in period ends.
Unlisted shares are less liquid than listed shares. You can sell when a buyer is available through an off-market transfer; there is no continuous exchange market, so exits can take longer.
Unlisted shares carry higher risk and lower liquidity than listed shares, with fewer disclosures and no live market price. This is general information, not investment advice — assess suitability before investing.
An unlisted share price is an indicative, over-the-counter reference set by demand and supply in private deals between buyers and sellers. There is no live exchange quote, so prices can vary across dealers and over time.
Yes. Unlisted shares are delivered in dematerialised form, so you need an active demat account (NSDL or CDSL). No special account type is required — a regular demat account works.
Unlisted shares are sold through an off-market transfer to a buyer via a registered intermediary, settling from your demat account with a contract note. Liquidity depends on buyer availability, so exits can take longer than listed shares.
Sigachi Laboratories Limited vs similar unlisted Healthcare shares
Indicative over-the-counter prices, as of 16 July 2026. Information only — not a recommendation or ranking.